Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

Ideaya Biosciences(IDYA.US)

Event Tracking

Apr13

IDEAYA Biosciences' drug darovasertib meets main goal in clinical trial, shares surge

10:16

IDEAYA Biosciences and Servier's Combined Therapy Phase 2/3 Trial Achieves Positive Topline Results

10:01

Apr10

IDEAYA Biosciences to Release Topline Results of Phase 2/3 OptimUM-02 Trial for Metastatic Uveal Melanoma

20:05

Apr9

IDEAYA Biosciences and AstraZeneca Agree to Test IDE849 Drug

10:15

Mar30

IDEAYA Biosciences Enrolls First Patient in Phase 1 Combination Study

10:01

Mar22

IDEAYA Biosciences to Discuss Phase 2/3 OptimUM-02 Trial Topline Results

14:00

Schedules & Filings

Schedules

Filings

Feb17

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 10.88 M, Net Income -83.27 M, EPS -0.944

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 207.83 M, Net Income 119.24 M, EPS 1.33

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -77.49 M, EPS -0.8758

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

Ideaya Biosciences(IDYA.US)

Ideaya Biosciences Stock Performance Chart